Vericel (VCEL)
(Delayed Data from NSDQ)
$35.63 USD
+0.69 (1.97%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $35.64 +0.01 (0.03%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Vericel Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VCEL 35.63 +0.69(1.97%)
Will VCEL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VCEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VCEL
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
VCEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates
Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates
Travere Therapeutics (TVTX) Reports Q1 Loss, Tops Revenue Estimates
Other News for VCEL
Vericel (VCEL) Price Target Reduced Despite Solid Earnings
Vericel price target lowered by $3 at Canaccord, here's why
Canaccord Genuity Lowers Price Target on Vericel (VCEL) but Maintains 'Buy' Rating | VCEL Stock News
Vericel Corp (VCEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight